These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3096037)

  • 1. Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
    Ross RJ; Grossman A; Besser GM; Savage MO
    Acta Endocrinol Suppl (Copenh); 1986; 279():123-9. PubMed ID: 3096037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing hormone: studies in normal subjects and patients with disorders of growth hormone secretion.
    Ross RJ; Grossman A
    Pediatrician; 1987; 14(3):138-45. PubMed ID: 3134650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-hormone-releasing hormone.
    Vance ML
    Clin Chem; 1990 Mar; 36(3):415-20. PubMed ID: 2107038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies with GHRH in man.
    Thorner MO; Vance ML; Evans WS; Rogol AD; Rivier J; Vale W; Blizzard RM
    Horm Res; 1986; 24(2-3):91-8. PubMed ID: 3093355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) profiles with successive provocation by GH-releasing hormone and arginine in children: a clinical appraisal.
    Sato T; Igarashi N; Miyagawa K; Shimizu M; Nishikawa T
    Endocrinol Jpn; 1991 Feb; 38(1):33-8. PubMed ID: 1915111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone: therapeutic perspectives.
    Gelato MC; Malozowski S; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    Pediatrician; 1987; 14(3):162-7. PubMed ID: 3134651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion.
    Martha PM; Blizzard RM; McDonald JA; Thorner MO; Rogol AD
    J Clin Endocrinol Metab; 1988 Sep; 67(3):449-54. PubMed ID: 2900843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth hormone-releasing hormone. The physiopathologic aspects and its diagnostic-therapeutic use].
    De Marinis L; Mancini A; La Brocca A; D'Amico C; Sambo P; Tofani A; Barbarino A
    Minerva Med; 1989 Apr; 80(4):325-34. PubMed ID: 2566960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-releasing hormone: clinical studies and therapeutic aspects.
    Low LC
    Neuroendocrinology; 1991; 53 Suppl 1():37-40. PubMed ID: 1901390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
    Blacklay A; Grossman A; Ross RJ; Savage MO; Davies PS; Plowman PN; Coy DH; Besser GM
    J Endocrinol; 1986 Jan; 108(1):25-9. PubMed ID: 2868066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
    Tauber MT; Pienkowski C; Landier F; Gunnarsson R; Rochiccioli P
    Acta Paediatr Scand Suppl; 1989; 349():117-22; discussion 123-4. PubMed ID: 2546370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of beta 1-adrenergic blockade on the growth response to growth hormone (GH)-releasing hormone therapy in GH-deficient children.
    Cassorla F; Mericq V; García H; Cristiano A; Avila A; Boric A; Iñiguez G; Merriam GR
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2997-3001. PubMed ID: 7559887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J; Kiess W; Kratzsch J; Nowak T; Steinkamp H; Willgerodt H; Keller E
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immunoreactive growth hormone releasing hormone concentrations and growth hormone response to growth hormone releasing hormone in short children.
    Tapanainen PJ
    Eur J Pediatr; 1993 Dec; 152(12):984-9. PubMed ID: 8131817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C; Hindmarsh PC; Pringle PJ; Brook CG
    Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.